標籤彙整: GLP-1

減重門診熱門藥物：認識「瘦瘦筆」與口服減重藥的原理與使用

當我們努力進行了飲食控制與規律運動，體重卻依然停滯不前，或者因為食慾過於旺盛、難以克服對甜食與油炸物的渴望時，繼續閱讀 “減重門診熱門藥物：認識「瘦瘦筆」與口服減重藥的原理與使用”

What Are GLP-1 Receptor Agonists? Understanding the Gut Hormone That Changed Weight Loss Medicine

Learn what GLP-1 receptor agonists are, how the incretin hormone GLP-1 regulates appetite and blood sugar, and why these medications have transformed obesity medicine.

Wegovy (Semaglutide) Complete Guide: How It Works, Dosing Schedule, and Who Should Use It

A comprehensive guide to Wegovy (semaglutide 2.4mg): FDA approval, mechanism of action, the 16-week titration schedule, STEP trial results, side effects, and patient selection criteria.

Mounjaro & Zepbound (Tirzepatide) Complete Guide: The Dual GIP/GLP-1 Agonist Explained

Explore tirzepatide’s unique dual GIP and GLP-1 receptor agonism, the SURMOUNT-1 trial’s 22.5% weight loss results, dosing schedule, and differences between Mounjaro and Zepbound.

Step-by-Step Dosing and Titration Guide for GLP-1 RA Medications: Why Slow Titration Matters

Learn the exact dose escalation schedules for Wegovy and Zepbound, why slow titration reduces GI side effects, and when and how to delay or adjust dose increases.

How to Inject GLP-1 RA Medications Correctly: Site Selection, Pen Use, and Common Mistakes

Step-by-step guide to correct subcutaneous injection technique for Wegovy and Zepbound pens: approved injection sites, site rotation, common patient errors, and safety tips.

Proper Storage and Handling of GLP-1 RA Pens: Temperature, Travel, and Expiry Guidelines

Official storage requirements for Wegovy and Zepbound pens: refrigeration temperatures, room temperature limits, travel tips, freezing risks, and what to do with expired or damaged pens.

Who Is a Candidate for GLP-1 RA Medications? BMI Thresholds, Comorbidities, and FDA Approvals

Understand the BMI and comorbidity criteria for Wegovy and Zepbound eligibility, contraindications, and what medical evaluation is required before starting GLP-1 RA therapy.

The Dangers of Compounded Semaglutide and Tirzepatide: FDA Warnings, Quality Risks, and What Patients Must Know

FDA-approved GLP-1 RA medications have safe, verified formulations. Compounded versions carry serious risks including dosing errors, contamination, and unverified ingredients—here’s what you must know.